Wayfinding Financial’s ResMed RMD Stock Holding History

Wayfinding Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-319	Closed	-$71K	–	583
2025 Q1	$71K	Buy	+319	New	+$74.5K	0.03%	289

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wayfinding Financial's RMD Position: Q2 2025 in Review

Wayfinding Financial sold out of ResMed (RMD) in Q2 2025, closing a stake of 319 shares — an estimated $71K sold.

Wayfinding Financial first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $71K in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Wayfinding Financial reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Wayfinding Financial sold 319 ResMed shares in Q2 2025, an estimated $71K.
Wayfinding Financial first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
Wayfinding Financial's ResMed position peaked at $71K in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Wayfinding Financial's 13F filing for Q2 2025, filed 12 Aug 2025.